Apexigen, Inc. Net Income
Apexigen, Inc. reported Net Income of -$6.05 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2023-08-10
- Apexigen, Inc. net income (loss) attributable to parent for the quarter ending 2023-06-30 was -$6.05M.
- Apexigen, Inc. net income (loss) attributable to parent for the quarter ending 2023-03-31 was -$6.05M.
- Apexigen, Inc. net income (loss) attributable to parent for the quarter ending 2022-12-31 was -$6.43M.
- Apexigen, Inc. net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$8.49M.
- Apexigen, Inc. net income (loss) attributable to parent for fiscal 2022 was -$32.07M.
- Apexigen, Inc. net income (loss) attributable to parent for fiscal 2021 was -$28.92M.
| Period end | Net Income (Loss) Attributable to Parent 1 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 4 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 7 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$6.05M 10-Q · filed 2023-08-10 | -$12.10M 10-Q · filed 2023-08-10 | -$18.53M derived: sum of 3 quarters · filed 2023-08-10 | -$27.02M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2023-03-31 | -$6.05M 10-Q · filed 2023-05-15 | -$12.48M derived: sum of 2 quarters · filed 2023-05-15 | -$20.98M derived: sum of 3 quarters · filed 2023-05-15 | -$29.08M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-12-31 | -$6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$14.92M derived: sum of 2 quarters · filed 2023-02-22 | -$23.03M derived: sum of 3 quarters · filed 2023-08-10 | -$32.07M 10-K · filed 2023-02-22 | |||||||
| 2022-09-30 | -$8.49M 10-Q · filed 2022-11-14 | -$16.60M derived: sum of 2 quarters · filed 2023-08-10 | -$25.64M 10-Q · filed 2022-11-14 | -$33.73M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-06-30 | -$8.10M 10-Q · filed 2023-08-10 | -$1.67M 10-Q · filed 2022-08-18 | -$17.15M 10-Q · filed 2023-08-10 | -$4.13M 10-Q · filed 2022-08-18 | -$25.24M derived: sum of 3 quarters · filed 2023-08-10 | -$32.54M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | -$9.04M 10-Q · filed 2023-05-15 | -$2.46M 10-Q · filed 2022-05-23 | -$17.14M derived: sum of 2 quarters · filed 2023-05-15 | -$24.44M derived: sum of 3 quarters · filed 2023-05-15 | -$24.72M derived: sum of 4 quarters · filed 2023-05-15 | ||||||
| 2021-12-31 | -$8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$15.39M derived: sum of 2 quarters · filed 2023-02-22 | -$15.68M derived: sum of 3 quarters · filed 2023-02-22 | -$28.92M 10-K · filed 2023-02-22 | -$484.06K 10-K · filed 2022-04-07 | ||||||
| 2021-09-30 | -$7.30M 10-Q · filed 2022-11-14 | $75.37K 10-Q · filed 2021-12-09 | -$7.58M derived: sum of 2 quarters · filed 2022-11-14 | -$20.82M 10-Q · filed 2022-11-14 | -$376.20K 10-Q · filed 2021-12-09 | ||||||
| 2021-06-30 | -$281.58K 10-Q · filed 2022-08-18 | -$451.58K 10-Q · filed 2022-08-18 | |||||||||
| 2021-03-31 | -$170.00K 10-Q · filed 2022-08-18 | ||||||||||
| 2020-12-31 | -$1.83K 10-K · filed 2022-04-07 | ||||||||||
| 2020-09-30 | -$1.10K 10-Q · filed 2021-12-09 | -$1.83K 10-Q · filed 2021-12-09 | |||||||||
| 2020-06-30 | -$729.00 10-Q · filed 2021-12-09 |